Theres simply no way to know
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
They cover peptide basics, the preclinical evidence for BPC-157 and TB-500, mechanisms like angiogenesis and tissue repair, the lack of robust human trials, sourcing risks, regulatory bans, and the gap between anecdotal reports and scientific certainty
It is essential to follow a healthcare providers instructions precisely
Request references or review publicly available feedback from other healthcare providers
This evidence-based approach avoids unnecessary costs and complexity while ensuring people who truly benefit from b12 addition receive appropriate supplementation